864 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Strong Sales in the 3rd Quarter of 2010 Vétoquinol’s revenues for the third quarter of 2010 rose by 10.8%. This healthy rate of growth was attributable mainly to strong performance in the Group’s strategic regions and therapeutic segments. |
19/10/2010 | Public releases | |
Sustainable development, an integral part of Vetoquinol Vetoquinol's corporate vision underlines its ambition for its entire ecosystem. This vision creates a dynamic for sustainable development by stating that by 2033 the company will be "the most agile animal health laboratory where employees, experts, partners, and customers work together to create customized solutions dedicated to animal health for a better planet". |
13/09/2023 | Press releases communication | |
Sustained revenue growth in 2006 |
15/02/2007 | Public releases | |
The reference products demonstrate solid growth Lure (France), August 29, 2013 – At its meeting on August 27, 2013, the Vétoquinol S.A. Board of Directors reviewed the Group’s results, and approved the financial statements for the first six months of 2013. |
29/08/2013 | Public releases | |
Third quarter revenues: €132 million |
14/10/2021 | Public releases | |
Universal registration document 2021 Universal Registration Document including the Annual Financial Report |
05/05/2022 | Reference document | |
Universal registration document 2022 Universal Registration Document including the Annual Financial Report |
05/05/2023 | Reference document | |
Universal registration document 2023 Universal Registration Document including the Annual Financial Report |
24/04/2024 | Reference document | |
Universal registration document 2023 XBRL version Universal Registration Document including the Annual Financial Report |
24/04/2024 | Reference document | |
Update July 11, 2023 2023 CALENDAR OF FINANCIAL COMMUNICATION Update July 11, 2023 |
12/07/2023 | Agenda |